Quick summary
Palmitoylethanolamide is a fatty acid amide studied as a dietary supplement mainly within the fatty acids and lipids category. Current compiled evidence is research pending and does not establish confirmed clinical benefits or safety profiles.
What is it?
Palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide belonging to the chemical group of fatty acids and lipids. It is being investigated as a nutritional supplement, although it has not been established as an essential nutrient. Its biological roles and potential supplement uses remain under scientific exploration.
How it may work in the body
While there are proposed mechanisms of action for palmitoylethanolamide, such as involvement in cellular signalling related to fatty acid metabolism, these mechanisms are not detailed in the supplied evidence. The clinical relevance or confirmed biological effects of these mechanisms have not been established with human clinical data.
Common supplement forms
The supplied evidence does not provide specific information regarding common supplement forms, such as capsules, powders, or other delivery methods, for palmitoylethanolamide.
Typical dosage and how it is used
No specific typical dosage information or official recommended daily intake is available based on the supplied research. There is no established official recommended daily intake (RDA) or adequate intake (AI) for palmitoylethanolamide. As such, guidance on dosing and usage remains unclear.
Natural sources
Data on natural dietary sources of palmitoylethanolamide were not supplied. Therefore, its presence in foods and typical dietary intake levels are currently not well described.
Absorption and bioavailability
No data are available on the absorption, bioavailability, or factors that may enhance or inhibit the uptake and metabolism of palmitoylethanolamide from supplements or natural sources.
Potential benefits: what does the evidence say?
The current evidence base for palmitoylethanolamide is insufficient to establish clear human clinical benefits. There are no consistent findings from clinical trials or systematic reviews supporting its efficacy for any health-related outcomes.
The lack of substantial human evidence limits conclusions regarding any supplement benefit.
Side effects and safety
The available evidence does not specify common side effects, safety concerns, or contraindications related to palmitoylethanolamide supplementation. Information on toxicity, overuse, or special population considerations is also lacking.
Drug and supplement interactions
No data regarding interactions between palmitoylethanolamide and drugs or other supplements are provided in the available evidence. Therefore, potential interaction risks remain unknown.
Who should be careful?
Due to limited safety information, individuals who are pregnant, breastfeeding, have medical conditions, or use medications should exercise caution. Consultation with a healthcare professional is recommended prior to use in these groups.
Pregnancy, breastfeeding and special populations
No safety or efficacy information for palmitoylethanolamide use during pregnancy, breastfeeding, or in special populations such as children or elderly individuals is available from the supplied data. Medical guidance is advised before considering supplementation in these groups.
Quality, standardization and what to look for
No specific quality standards, standardization measures, or certification details were included in the evidence. For supplements in general, selecting products from reputable manufacturers with third-party testing may help ensure quality, though no palmitoylethanolamide-specific guidance can be given at this time.
Frequently asked questions
- Is palmitoylethanolamide an essential nutrient?
No, palmitoylethanolamide is not classified as an essential nutrient. - Are there any approved health claims for palmitoylethanolamide in the EU?
No EU-authorized health claims were provided in the available evidence. - What is the recommended dosage?
There is no official recommended daily intake or typical dosage established based on current evidence. - Is it safe to take palmitoylethanolamide supplements?
Safety data are limited; speak with a healthcare professional especially if pregnant, breastfeeding, or taking medications. - Are there natural food sources?
Specific dietary sources were not identified in the supplied information.
Evidence limitations
- Available evidence is labeled as research pending, indicating insufficient clinical data to support efficacy or safety claims.
- No official or regulatory authoritative sources (e.g., EFSA, NIH ODS) provide health claims or intake recommendations.
- There is a lack of strong human clinical trials or systematic reviews available to establish benefit or safety.
- Safety and interaction data are incomplete.
References
Last reviewed
June 2024
Disclaimer: This page is for informational purposes only and does not constitute medical advice. Palmitoylethanolamide supplements have not been confirmed to treat, prevent, or cure any disease. Individuals should consult healthcare professionals before starting any new supplement, especially if pregnant, breastfeeding, have existing health conditions, or take medications.